Wipro introduces regulatory literature monitoring for pharmaceutical organizations

15 Dec 2021 Evaluate

Wipro has introduced regulatory literature monitoring for pharmaceutical organizations by entering a managed services engagement with Springer Nature. Drug safety, referred to as Pharmacovigilance (PV), constitutes the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. PV departments in Life Sciences organizations, to fulfill drug safety requirements, leverage literature monitoring that includes Annual Reports, Periodic Safety Update Reports, Individual Case Study Report (ICSR) Monitoring, among others.

Wipro is a leading global information technology, consulting and business process services company.

Wipro Share Price

260.00 3.05 (1.19%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
TCS 3238.90
Infosys 1615.95
HCL Tech. 1682.85
Wipro 260.00
Tech Mahindra 1569.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×